US Patent 7722718 Methods for crystallizing ERK2 polypeptides
Patent 7722718 was granted and assigned to Schering on May, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+168 characters)
Article
Patent abstract
The present invention relates to crystals of the ERK2 polypeptide and complexes thereof which are useful, inter alia, for structure assisted drug design.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+8 properties)
Infobox
Patent Inventor Names
Alan William Hruza0
Catherine Smith0
Jessie English0
Paul Reichert0
Shahriar Shane Taremi0
Thierry Oliver Fischmann0
Thomas Hesson0
Weihong Jin0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07722718 Methods for crystallizing ERK2 polypeptides US Patent 7722718 Methods for crystallizing ERK2 polypeptides
Infobox
Patent Number
077227180
Patent Number
77227180
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077227180
Date of Patent
May 25, 2010
0Patent Application Number
118738310
Date Filed
October 17, 2007
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07722718 Methods for crystallizing ERK2 polypeptides
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07722718
Date of patent
May 25, 2010
Patent application number
11873831
Date Filed
October 17, 2007
Patent primary examiner
Find more entities like US Patent 7722718 Methods for crystallizing ERK2 polypeptides
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
